Stock Updates

Today’s Top Gainers in the Market Teva Pharmaceutical Industries Limited (NYSE:TEVA) from Healthcare

Today’s top gainers include the company Teva Pharmaceutical Industries Limited (NYSE:TEVA) which is in the industry Drug Manufacturers – Other, gaining -3.61% today. In the last week its performance is -4.68%, and -7.30% for the past quarter. Currently, Teva Pharmaceutical Industries Limited, TEVA has a target price of 40.04, so today’s gain of -3.61% is a significant step towards its target price. The GAP today is therefore -0.84%.

Teva Pharmaceutical Industries Limited (NYSE:TEVA), has a market cap of 31355.37, and is based in Israel. Insider ownership is at 2.70%, and institutional ownership is 63.10%.

At the current price of 30.99, it has a dividend yield of 4.39%, and its target price is 40.04. This is with a profit margin of 0.30%, and total debt/equity of 1.2. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a P/E of 199.94, as well as a forward P/E of 6.47.

With a current EPS of 0.16, and a forecasted EPS growth for next year at -0.60%,Teva Pharmaceutical Industries Limited (NYSE:TEVA) has had a EPS growth for the past five years at -53.00%. For the next five years EPS growth is projected to be 1.83%.

Performance for the year is -41.83%. Since its IPO date on 3/26/1990, the total performance to date is -13.69%.

Volume today for Teva Pharmaceutical Industries Limited (NYSE:TEVA), is 9604200, while its average volume is 9313.7. Whilst the total gain today was -3.61%, it did have a day high of -17.53%.

Volatility for this week has been at 1.61%, and 1.84% for the month. The 52-week low for Teva Pharmaceutical Industries Limited, TEVA has been -1.92%, while the 52-week-high has reached -45.00%.

Looking at its return of investments, which is 1.10%, and its return on assets is 0.10%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an operating margin of 9.80%. With a sales growth of 33.00% quarter over quarter. Bearing in mind that Teva Pharmaceutical Industries Limited, TEVA is in the sector Healthcare, its long-term debt/equity is 1.09, and has a current ratio of 0.9 and 0.6 for quick ratio.

So what is the value of Teva Pharmaceutical Industries Limited? Well its PEG is 109.02, and the P/S is 1.43, along with a P/B of 1.06. Meanwhile it has a p/cash of 31.42.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment